C4 Therapeutics, Inc
CCCC
NASDAQ
Biotechnology
$4.24
USD
+0.16 (+3.92%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $497.64M
Volume 3.4M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
SPRY | ARS Pharmaceuticals Inc | $605.75M | - | +1.9% | - | |
VSTM | Verastem Inc | $586.12M | - | +209.1% | - | |
ZURA | Zura Bio Ltd | $566.81M | - | - | - | |
MPLT | MapLight Therapeutics Inc | $519.09M | - | - | - | |
OVID | Ovid Therapeutics Inc | $518.86M | - | +1199.6% | - | |
CCCC | C4 Therapeutics, Inc | $497.64M | - | -12.4% | - | |
KYTX | Kyverna Therapeutics Inc | $479.67M | - | - | - | |
OCGN | Ocugen Inc | $457.80M | - | +0.4% | - | |
PBYI | Puma Biotechnology Inc | $454.88M | 18.65 | -2.4% | - |
Top Peer by Growth
Ovid Therapeutics Inc
+1199.6% YoY Revenue
Lowest P/E Ratio
Puma Biotechnology Inc
18.65x P/E
Best 1-Year Return
Zura Bio Ltd
+254.1% Return